|
Balaxi Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
288.57 Cr.
|
P/BV
|
1.34
|
Book Value (Rs.)
|
39.10
|
|
52 Week High/Low (Rs.)
|
151/50
|
FV/ML
|
2/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/05/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -2.32 | 45.81 | 47.66 | 38.14 | 8.12 |
| Diluted EPS (Rs.) | -2.31 | 45.40 | 47.66 | 38.14 | 8.12 |
| Cash EPS (Rs.) | -0.26 | 46.87 | 48.17 | 38.44 | 6.11 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 184.77 | 179.62 | 113.16 | 64.98 | 27.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 184.77 | 179.62 | 113.16 | 64.98 | 27.75 |
| Revenue From Operations / Share (Rs.) | 221.41 | 330.44 | 279.39 | 231.33 | 45.63 |
| PBDIT / Share (Rs.) | 40.45 | 58.12 | 55.18 | 44.64 | 8.88 |
| PBIT / Share (Rs.) | 38.53 | 56.40 | 54.66 | 44.34 | 8.87 |
| PBT / Share (Rs.) | 1.85 | 55.91 | 54.52 | 44.33 | 8.87 |
| Net Profit / Share (Rs.) | -2.19 | 45.14 | 47.66 | 38.14 | 6.10 |
| NP After MI And SOA / Share (Rs.) | -2.19 | 45.14 | 47.66 | 38.14 | 6.10 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 18.26 | 17.58 | 19.74 | 19.29 | 19.46 |
| PBIT Margin (%) | 17.40 | 17.06 | 19.56 | 19.16 | 19.44 |
| PBT Margin (%) | 0.83 | 16.91 | 19.51 | 19.16 | 19.44 |
| Net Profit Margin (%) | -0.98 | 13.66 | 17.05 | 16.48 | 13.37 |
| NP After MI And SOA Margin (%) | -0.98 | 13.66 | 17.05 | 16.48 | 13.37 |
| Return on Networth / Equity (%) | -1.18 | 25.13 | 42.11 | 58.69 | 21.99 |
| Return on Capital Employeed (%) | 20.56 | 30.78 | 48.28 | 68.23 | 31.97 |
| Return On Assets (%) | -0.92 | 19.17 | 27.00 | 38.25 | 16.96 |
| Total Debt / Equity (X) | 0.08 | 0.06 | 0.03 | 0.05 | 0.00 |
| Asset Turnover Ratio (%) | 0.96 | 1.62 | 2.02 | 3.41 | 2.17 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 3.88 | 3.64 | 2.23 | 2.70 | 4.24 |
| Quick Ratio (X) | 2.36 | 1.67 | 0.66 | 2.31 | 4.14 |
| Inventory Turnover Ratio (X) | 1.37 | 1.99 | 3.48 | 23.83 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 1.08 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 1.04 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 98.92 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 98.96 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 26.29 | 118.35 | 389.66 | 3407.65 | 0.00 |
| Interest Coverage Ratio (Post Tax) (%) | 22.41 | 92.92 | 337.57 | 2912.25 | 0.00 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 495.85 | 523.37 | 348.05 | 526.49 | 70.00 |
| EV / Net Operating Revenue (X) | 2.05 | 1.56 | 1.25 | 2.28 | 1.53 |
| EV / EBITDA (X) | 11.25 | 8.84 | 6.31 | 11.79 | 7.88 |
| MarketCap / Net Operating Revenue (X) | 2.24 | 1.60 | 1.26 | 2.27 | 1.62 |
| Retention Ratios (%) | 0.00 | 98.91 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 2.68 | 2.95 | 3.11 | 8.07 | 2.67 |
| Price / Net Operating Revenue (X) | 2.24 | 1.60 | 1.26 | 2.27 | 1.62 |
| EarningsYield | 0.00 | 0.08 | 0.13 | 0.07 | 0.08 |
